From professional translators, enterprises, web pages and freely available translation repositories.
beenmergsuppressie
myelosuppression
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ernstige beenmergsuppressie
profound bone marrow suppression
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
basiliximab veroorzaakt geen beenmergsuppressie.
basiliximab does not cause myelosuppression.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
beenmergsuppressie; leukopenie en trombocytopenie
bone marrow suppression; leucopenia and thrombocytopenia
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ernstige nier- of leverfunctiestoornis en ernstige beenmergsuppressie
severe renal or hepatic failure and severe myelosuppression
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
beenmergsuppressie en andere hematologische bijwerkingen zijn gemeld.
bone marrow suppression and other haematologic adverse reactions have been reported.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
beenmergsuppressie (inclusief anemie, neutropenie, trombocytopenie)
myelosuppression (including anaemia, neutropaenia, thrombocytopaenia)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
beenmergsuppressie was de voornaamste dosisbeperkende toxiciteit van paxene.
bone marrow suppression was the major dose-limiting toxicity of paxene.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
de belangrijkste te verwachten complicatie bij overdosering is beenmergsuppressie.
the primary anticipated complication of an overdose is bone marrow suppression.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bij patiënten met aanhoudende beenmergsuppressie is hematopoëtische groeifactor gebruikt.
haematopoietic growth factor has been used in patients with resistant myelosuppression.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
beenmergsuppressie (voornamelijk neutropenie) treedt vaak op met abraxane.
bone marrow suppression (primarily neutropenia) occurs frequently with abraxane.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
de primaire complicaties van overdosering zijn naar verwachting beenmergsuppressie en mucositis.
the primary complications of overdose are anticipated to be bone marrow suppression and mucositis.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
beenmergsuppressie (myelosuppressie) was de voornaamste dosisbeperkende toxiciteit van paxene.
bone marrow suppression was the major dose-limiting toxicity of paxene.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
als gevolg van de kortwerkende activiteit induceert oestriol geen beenmergsuppressie in de hond.
because of its short acting action, oestriol does not induce bone marrow suppression in the dog.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
de belangrijkste te verwachten toxiciteiten zijn maag-darmproblemen, beenmergsuppressie en levertoxiciteit.
the major anticipated toxicities are gastrointestinal, bone marrow suppression and hepatic toxicity.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
beenmergsuppressie is reversibel als het gebruik van 6-mercaptopurine tijdig wordt gestaakt.
bone marrow suppression is reversible if 6–mercaptopurine is withdrawn early enough.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bij de meeste patiënten kon de behandeling worden voortgezet zonder verdere verschijnselen van beenmergsuppressie.
most patients continued treatment without further evidence of myelosuppression.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tot de verwachte complicaties van overdosering behoren beenmergsuppressie die zich uit in neutropenie, trombocytopenie en anemie.
anticipated complications of overdose include bone marrow suppression as manifested by neutropenia, thrombocytopenia and anaemia.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
de behandeling moet worden toegespitst op de voornaamste verwachte toxiciteit zoals beenmergsuppressie, mucositis en perifere neuropathie.
treatment should be directed at the major anticipated toxicities, which are bone marrow suppression, mucositis and peripheral neuropathy.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
in de doeldierveiligheidsstudie en in de klinische proeven, inclusief langdurige behandeling, werden geen tekenen van beenmergsuppressie waargenomen.
in the target animal safety study and the clinical trials, including long-term treatment, no signs of bone marrow suppression were observed.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: